Proyecto de Titulación embargado con fines de publicación de impacto

Abstract

Human papillomavirus (HPV) is responsible for 80% of cases of cervical cancer (CCU), worldwide it is placed in the fourth place of the most common cancers, this disease is preventable through the application of the vaccine, however, this vaccine has low acceptance compared to other vaccines (tetanus, diphtheria, etc). The vaccine is applied to girls who range the ages of 9 and 12, in two doses with an interval of 6 months between each dose, for this reason parents are the ones who play a very important role in accepting the vaccine. According to the results of several researches, the acceptability of the vaccine is good, nevertheless, there may be numerous barriers that prevent vaccination, such as: the lack of knowledge regarding the human papillomavirus and the vaccine which is found more frequently in the male gender since they consider not be at risk, the myths about the adverse effects of the vaccine and in certain regions the cost of it, all this leading to reduce the acceptability of the vaccine against the human papilloma virus. According to the results obtained in this study, the acceptability of the vaccine is relatively good. These results may vary depending on the type of population under study, since they are closely related to certain factors and barriers that may influence the perception and acceptability of the vaccine